Literature DB >> 27988219

Dietary Changes Impact the Gut Microbe Composition in Overweight and Obese Men with Prostate Cancer Undergoing Radical Prostatectomy.

Andrew D Frugé, Travis Ptacek, Yuko Tsuruta, Casey D Morrow, Maria Azrad, Renee A Desmond, Gary R Hunter, Soroush Rais-Bahrami, Wendy Demark-Wahnefried.   

Abstract

BACKGROUND: Diet and obesity influence prostate cancer risk and progression-effects that may be mediated through the gut microbiome.
OBJECTIVE: Our aim was to explore relationships among diet, gut microbes, and Gleason sum in overweight and obese prostate cancer patients enrolled in a presurgical weight-loss trial.
DESIGN: Randomized controlled trial (NCT01886677) secondary analysis. PARTICIPANTS/
SETTING: In 2013-2014, 40 prostate cancer patients in the southeastern United States were randomized and allocated equally to weight-loss and wait-list control arms while they awaited prostatectomy; stool samples were collected on a subset of 22 patients. INTERVENTION: Registered dietitian nutritionists and exercise physiologists provided semi-weekly in-person and telephone-based guidance on calorie-restricted diets and exercise to promote an approximate weight loss of 0.91 kg/wk. MAIN OUTCOME MEASURES: Baseline and follow-up 24-hour dietary recalls were conducted and analyzed (using the Automated Self-Administered 24-hour dietary recall system; National Cancer Institute, Bethesda, MD) for macronutrients, micronutrients, and food groups. Microbiome analysis targeting the V4 region of the 16S ribosomal RNA gene was performed on fecal samples. Biopsy Gleason sum data were accessed from diagnostic pathology reports. STATISTICAL ANALYSES PERFORMED: Associations between dietary factors and operational taxonomic units were determined by β-diversity analysis. Wilcoxon signed rank, and Mann-Whitney U testing assessed within- and between-arm differences. Associations between Gleason sum and operational taxonomic units, and diet and operational taxonomic units, were analyzed using Spearman correlations.
RESULTS: At baseline, Proteobacteria (median 0.06, interquartile range 0.01 to 0.16) were abundant, with four orders positively associated with Gleason sum. Gleason sum was associated with Clostridium (ρ=.579; P=0.005) and Blautia (ρ=-0.425, P=0.049). Increased red meat consumption from baseline was associated with Prevotella (ρ=-.497; P=0.018) and Blautia (ρ=.422; P=0.039). Men who increased poultry intake had decreased Clostridiales abundance (P=0.009).
CONCLUSIONS: This hypothesis-generating study provides a starting point for investigating the relationships between the fecal microbiome, diet, and prostate cancer. Adequately powered studies are required to further explore and validate these findings.
Copyright © 2018 Academy of Nutrition and Dietetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diet; Gastrointestinal microbiome; Obesity; Prostatic neoplasms; Proteobacteria

Mesh:

Year:  2016        PMID: 27988219      PMCID: PMC5471140          DOI: 10.1016/j.jand.2016.10.017

Source DB:  PubMed          Journal:  J Acad Nutr Diet        ISSN: 2212-2672            Impact factor:   4.910


  51 in total

Review 1.  Toll-like receptor-gut microbiota interactions: perturb at your own risk!

Authors:  Frederic A Carvalho; Jesse D Aitken; Matam Vijay-Kumar; Andrew T Gewirtz
Journal:  Annu Rev Physiol       Date:  2011-10-24       Impact factor: 19.318

2.  Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation.

Authors:  Les Dethlefsen; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-16       Impact factor: 11.205

Review 3.  The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.

Authors:  Jonathan I Epstein; William C Allsbrook; Mahul B Amin; Lars L Egevad
Journal:  Am J Surg Pathol       Date:  2005-09       Impact factor: 6.394

4.  Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB.

Authors:  T Z DeSantis; P Hugenholtz; N Larsen; M Rojas; E L Brodie; K Keller; T Huber; D Dalevi; P Hu; G L Andersen
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

5.  Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life.

Authors:  Fredrik Bäckhed; Josefine Roswall; Yangqing Peng; Qiang Feng; Huijue Jia; Petia Kovatcheva-Datchary; Yin Li; Yan Xia; Hailiang Xie; Huanzi Zhong; Muhammad Tanweer Khan; Jianfeng Zhang; Junhua Li; Liang Xiao; Jumana Al-Aama; Dongya Zhang; Ying Shiuan Lee; Dorota Kotowska; Camilla Colding; Valentina Tremaroli; Ye Yin; Stefan Bergman; Xun Xu; Lise Madsen; Karsten Kristiansen; Jovanna Dahlgren; Jun Wang; Wang Jun
Journal:  Cell Host Microbe       Date:  2015-05-13       Impact factor: 21.023

Review 6.  Gut microbiota and obesity: role in aetiology and potential therapeutic target.

Authors:  Carthage P Moran; Fergus Shanahan
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-07-11       Impact factor: 3.043

7.  Diet quality of cancer survivors and noncancer individuals: Results from a national survey.

Authors:  Fang Fang Zhang; Shanshan Liu; Esther M John; Aviva Must; Wendy Demark-Wahnefried
Journal:  Cancer       Date:  2015-10-13       Impact factor: 6.860

Review 8.  Insights into the role of the microbiome in obesity and type 2 diabetes.

Authors:  Annick V Hartstra; Kristien E C Bouter; Fredrik Bäckhed; Max Nieuwdorp
Journal:  Diabetes Care       Date:  2015-01       Impact factor: 19.112

9.  Structure, function and diversity of the healthy human microbiome.

Authors: 
Journal:  Nature       Date:  2012-06-13       Impact factor: 49.962

Review 10.  Can weight loss prevent cancer?

Authors:  K Y Wolin; G A Colditz
Journal:  Br J Cancer       Date:  2008-08-26       Impact factor: 7.640

View more
  11 in total

1.  Gut microbial differences in breast and prostate cancer cases from two randomised controlled trials compared to matched cancer-free controls.

Authors:  K S Smith; A D Frugé; W van der Pol; N E Caston; C D Morrow; W Demark-Wahnefried; T L Carson
Journal:  Benef Microbes       Date:  2021-04-01       Impact factor: 4.205

Review 2.  Metagenomics in diagnosis and improved targeted treatment of UTI.

Authors:  Matthew Dixon; Maria Stefil; Michael McDonald; Truls Erik Bjerklund-Johansen; Kurt Naber; Florian Wagenlehner; Vladimir Mouraviev
Journal:  World J Urol       Date:  2019-04-03       Impact factor: 4.226

Review 3.  White adipose tissue-derived factors and prostate cancer progression: mechanisms and targets for interventions.

Authors:  Achinto Saha; Jill Hamilton-Reeves; John DiGiovanni
Journal:  Cancer Metastasis Rev       Date:  2022-08-04       Impact factor: 9.237

4.  Phase II prospective randomized trial of weight loss prior to radical prostatectomy.

Authors:  Susanne M Henning; Colette Galet; Kiran Gollapudi; Joshua B Byrd; Pei Liang; Zhaoping Li; Tristan Grogan; David Elashoff; Clara E Magyar; Jonathan Said; Pinchas Cohen; William J Aronson
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-12-04       Impact factor: 5.554

5.  Reply to "Phase II prospective randomized trial of weight loss prior to radical prostatectomy".

Authors:  W Demark-Wahnefried; S Rais-Bahrami; R A Desmond; J B Gordetsky; M Azrad; A D Frugé; E S Yang; L A Norian; W E Grizzle
Journal:  Prostate Cancer Prostatic Dis       Date:  2018-04-24       Impact factor: 5.554

6.  Does exercise impact gut microbiota composition in men receiving androgen deprivation therapy for prostate cancer? A single-blinded, two-armed, randomised controlled trial.

Authors:  Robert U Newton; Claus T Christophersen; Ciaran M Fairman; Nicolas H Hart; Dennis R Taaffe; David Broadhurst; Amanda Devine; Raphael Chee; Colin I Tang; Nigel Spry; Daniel A Galvão
Journal:  BMJ Open       Date:  2019-04-14       Impact factor: 2.692

7.  A Dietary Intervention High in Green Leafy Vegetables Reduces Oxidative DNA Damage in Adults at Increased Risk of Colorectal Cancer: Biological Outcomes of the Randomized Controlled Meat and Three Greens (M3G) Feasibility Trial.

Authors:  Andrew D Frugé; Kristen S Smith; Aaron J Riviere; Rachel Tenpenny-Chigas; Wendy Demark-Wahnefried; Anna E Arthur; William M Murrah; William J van der Pol; Shanese L Jasper; Casey D Morrow; Robert D Arnold; Kimberly Braxton-Lloyd
Journal:  Nutrients       Date:  2021-04-07       Impact factor: 5.717

8.  Association of Novel Androgen Receptor Axis-Targeted Therapies With Diarrhea in Patients With Prostate Cancer: A Bayesian Network Analysis.

Authors:  Xingyu Xiong; Hang Xu; Sheng Wang; Xinyang Liao; Xianyanling Yi; Kun Jin; Haoran Lei; Shengjiang Bai; Shi Qiu; Lu Yang
Journal:  Front Med (Lausanne)       Date:  2022-01-24

Review 9.  Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper.

Authors:  Olga Golubnitschaja; Peter Kubatka; Alena Mazurakova; Marek Samec; Abdullah Alajati; Frank A Giordano; Vincenzo Costigliola; Jörg Ellinger; Manuel Ritter
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

10.  Biomarkers Associated With Tumor Ki67 and Cathepsin L Gene Expression in Prostate Cancer Patients Participating in a Presurgical Weight Loss Trial.

Authors:  Andrew D Frugé; Kristen S Smith; Jennifer R Bail; Soroush Rais-Bahrami; Wendy Demark-Wahnefried
Journal:  Front Oncol       Date:  2020-09-17       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.